Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
Yamashita T, Ogawa S, Sato T, Aizawa Y, Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, Kobayashi Y, Koretsune Y, Kumagai K, Niwano S, Okazaki O, Okumura K, Saku K, Tanabe T, Origasa H; J-BAF Investigators. Yamashita T, et al. Among authors: kobayashi y. Circ J. 2009 Jun;73(6):1020-7. doi: 10.1253/circj.cj-08-1061. Epub 2009 Apr 9. Circ J. 2009. PMID: 19359813 Free article. Clinical Trial.
Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.
Ozawa T, Toba K, Suzuki H, Kato K, Iso Y, Akutsu Y, Kobayashi Y, Takeyama Y, Kobayashi N, Yoshimura N, Akazawa K, Aizawa Y; EPO/AMI-I Pilot Study Researchers. Ozawa T, et al. Among authors: kobayashi y, kobayashi n. Circ J. 2010 Jul;74(7):1415-23. doi: 10.1253/circj.cj-10-0109. Epub 2010 May 22. Circ J. 2010. PMID: 20501957 Free article. Clinical Trial.
HotBalloon Ablation of the Pulmonary Veins for Paroxysmal AF: A Multicenter Randomized Trial in Japan.
Sohara H, Ohe T, Okumura K, Naito S, Hirao K, Shoda M, Kobayashi Y, Yamauchi Y, Yamaguchi Y, Kuwahara T, Hirayama H, YeongHwa C, Kusano K, Kaitani K, Banba K, Fujii S, Kumagai K, Yoshida H, Matsushita M, Satake S, Aonuma K. Sohara H, et al. Among authors: kobayashi y. J Am Coll Cardiol. 2016 Dec 27;68(25):2747-2757. doi: 10.1016/j.jacc.2016.10.037. J Am Coll Cardiol. 2016. PMID: 28007137 Free article. Clinical Trial.
Waon Therapy for Managing Chronic Heart Failure　- Results From a Multicenter Prospective Randomized WAON-CHF Study.
Tei C, Imamura T, Kinugawa K, Inoue T, Masuyama T, Inoue H, Noike H, Muramatsu T, Takeishi Y, Saku K, Harada K, Daida H, Kobayashi Y, Hagiwara N, Nagayama M, Momomura S, Yonezawa K, Ito H, Gojo S, Akaishi M, Miyata M, Ohishi M; WAON-CHF Study Investigators. Tei C, et al. Among authors: kobayashi y. Circ J. 2016;80(4):827-34. doi: 10.1253/circj.CJ-16-0051. Epub 2016 Mar 18. Circ J. 2016. PMID: 27001189 Free article. Clinical Trial.
Performance of Leadless Pacemaker in Japanese Patients vs. Rest of the World　- Results From a Global Clinical Trial.
Soejima K, Asano T, Ishikawa T, Kusano K, Sato T, Okamura H, Matsumoto K, Taguchi W, Stromberg K, Lande J, Kobayashi Y; Micra Transcatheter Pacing Study Group. Soejima K, et al. Among authors: kobayashi y. Circ J. 2017 Oct 25;81(11):1589-1595. doi: 10.1253/circj.CJ-17-0259. Epub 2017 May 30. Circ J. 2017. PMID: 28566657 Free article. Clinical Trial.
High-dose granulocyte-colony stimulating factor promotes neointimal hyperplasia in the early phase and inhibits neointimal hyperplasia in the late phase after vascular injury.
Shoji M, Iso Y, Kusuyama T, Omori Y, Soda T, Tsunoda F, Sato T, Koba S, Geshi E, Kobayashi Y, Katagiri T, Suzuki H. Shoji M, et al. Among authors: kobayashi y. Circ J. 2008 Nov;72(11):1885-93. doi: 10.1253/circj.cj-07-1037. Epub 2008 Oct 7. Circ J. 2008. PMID: 18838829 Free article.
10,564 results
You have reached the last available page of results. Please see the User Guide for more information.